{"id":6028,"date":"2021-09-09T00:00:50","date_gmt":"2021-09-09T00:00:50","guid":{"rendered":"https:\/\/bmj-chicken.bmj.com\/thebmj\/the-bmj-article\/regulatory-and-clinical-consequences-of-negative-confirmatory-trials-of-accelerated-approval-cancer-drugs-retrospective-observational-study\/"},"modified":"2021-09-09T05:50:00","modified_gmt":"2021-09-09T05:50:00","slug":"regulatory-and-clinical-consequences-of-negative-confirmatory-trials-of-accelerated-approval-cancer-drugs-retrospective-observational-study","status":"publish","type":"the-bmj-article","link":"https:\/\/bmj-chicken.bmj.com\/thebmj\/the-bmj-article\/regulatory-and-clinical-consequences-of-negative-confirmatory-trials-of-accelerated-approval-cancer-drugs-retrospective-observational-study\/","title":{"rendered":"Regulatory and clinical consequences of negative confirmatory trials of accelerated approval cancer drugs"},"featured_media":0,"template":"","categories":[],"tags":[],"content_type":[36],"editorial_panel":[],"channel_page":[44],"class_list":["post-6028","the-bmj-article","type-the-bmj-article","status-publish","hentry","article-type-research","channel-page-research"],"aioseo_notices":[],"meta_box":{"the_bmj_article-url":"\/content\/374\/bmj.n1959","the_bmj_article-description":"","the_bmj_article-the_bmj_article_image":[],"the_bmj_article-related_articles":[{"article_type":"","related_article_title":"","related_article_url":""}],"the_bmj_article-journal_name":"The BMJ"},"head_tags":[{"tag":"title","content":"Regulatory and clinical consequences of negative confirmatory trials of accelerated approval cancer drugs | The BMJ"},{"tag":"meta","attributes":{"name":"robots","content":"max-image-preview:large"}},{"tag":"link","attributes":{"rel":"canonical","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/the-bmj-article\/regulatory-and-clinical-consequences-of-negative-confirmatory-trials-of-accelerated-approval-cancer-drugs-retrospective-observational-study\/"}},{"tag":"meta","attributes":{"name":"generator","content":"All in One SEO (AIOSEO) 4.9.7.2"}},{"tag":"meta","attributes":{"property":"og:locale","content":"en_GB"}},{"tag":"meta","attributes":{"property":"og:site_name","content":"The BMJ | The BMJ: leading general medical journal. Research. Education. Comment"}},{"tag":"meta","attributes":{"property":"og:type","content":"article"}},{"tag":"meta","attributes":{"property":"og:title","content":"Regulatory and clinical consequences of negative confirmatory trials of accelerated approval cancer drugs | The BMJ"}},{"tag":"meta","attributes":{"property":"og:url","content":"https:\/\/bmj-chicken.bmj.com\/thebmj\/the-bmj-article\/regulatory-and-clinical-consequences-of-negative-confirmatory-trials-of-accelerated-approval-cancer-drugs-retrospective-observational-study\/"}},{"tag":"meta","attributes":{"property":"article:published_time","content":"2021-09-09T00:00:50+00:00"}},{"tag":"meta","attributes":{"property":"article:modified_time","content":"2021-09-09T05:50:00+00:00"}},{"tag":"meta","attributes":{"name":"twitter:card","content":"summary"}},{"tag":"meta","attributes":{"name":"twitter:title","content":"Regulatory and clinical consequences of negative confirmatory trials of accelerated approval cancer drugs | The BMJ"}},{"tag":"link","attributes":{"rel":"alternate","type":"application\/rss+xml","title":"The BMJ \u00bb Feed","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/feed\/"}},{"tag":"link","attributes":{"rel":"alternate","type":"application\/rss+xml","title":"The BMJ \u00bb Comments Feed","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/comments\/feed\/"}},{"tag":"link","attributes":{"rel":"alternate","title":"oEmbed (JSON)","type":"application\/json+oembed","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/oembed\/1.0\/embed?url=https%3A%2F%2Fbmj-chicken.bmj.com%2Fthebmj%2Fthe-bmj-article%2Fregulatory-and-clinical-consequences-of-negative-confirmatory-trials-of-accelerated-approval-cancer-drugs-retrospective-observational-study%2F"}},{"tag":"link","attributes":{"rel":"alternate","title":"oEmbed (XML)","type":"text\/xml+oembed","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/oembed\/1.0\/embed?url=https%3A%2F%2Fbmj-chicken.bmj.com%2Fthebmj%2Fthe-bmj-article%2Fregulatory-and-clinical-consequences-of-negative-confirmatory-trials-of-accelerated-approval-cancer-drugs-retrospective-observational-study%2F&format=xml"}},{"tag":"link","attributes":{"rel":"https:\/\/api.w.org\/","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/"}},{"tag":"link","attributes":{"rel":"alternate","title":"JSON","type":"application\/json","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/the-bmj-article\/6028"}},{"tag":"link","attributes":{"rel":"EditURI","type":"application\/rsd+xml","title":"RSD","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/xmlrpc.php?rsd"}},{"tag":"meta","attributes":{"name":"generator","content":"WordPress 6.9.4"}},{"tag":"link","attributes":{"rel":"shortlink","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/?p=6028"}},{"tag":"meta","attributes":{"property":"og:locale","content":"en_GB"}},{"tag":"meta","attributes":{"property":"og:site_name","content":"The BMJ"}},{"tag":"meta","attributes":{"property":"og:title","content":"Regulatory and clinical consequences of negative confirmatory trials of accelerated approval cancer drugs"}},{"tag":"meta","attributes":{"property":"og:url","content":"https:\/\/bmj-chicken.bmj.com\/thebmj\/the-bmj-article\/regulatory-and-clinical-consequences-of-negative-confirmatory-trials-of-accelerated-approval-cancer-drugs-retrospective-observational-study\/"}},{"tag":"meta","attributes":{"property":"og:type","content":"article"}},{"tag":"meta","attributes":{"property":"og:description","content":"The BMJ: leading general medical journal. Research. Education. Comment"}},{"tag":"meta","attributes":{"name":"twitter:title","content":"Regulatory and clinical consequences of negative confirmatory trials of accelerated approval cancer drugs"}},{"tag":"meta","attributes":{"name":"twitter:url","content":"https:\/\/bmj-chicken.bmj.com\/thebmj\/the-bmj-article\/regulatory-and-clinical-consequences-of-negative-confirmatory-trials-of-accelerated-approval-cancer-drugs-retrospective-observational-study\/"}},{"tag":"meta","attributes":{"name":"twitter:description","content":"The BMJ: leading general medical journal. Research. Education. Comment"}},{"tag":"meta","attributes":{"name":"twitter:card","content":"summary_large_image"}}],"_links":{"self":[{"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/the-bmj-article\/6028","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/the-bmj-article"}],"about":[{"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/types\/the-bmj-article"}],"type":[{"embeddable":true,"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/types\/the-bmj-article"}],"wp:attachment":[{"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/media?parent=6028"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/categories?post=6028"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/tags?post=6028"},{"taxonomy":"article-type","embeddable":true,"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/content_type?post=6028"},{"taxonomy":"editorial-panel","embeddable":true,"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/editorial_panel?post=6028"},{"taxonomy":"channel-page","embeddable":true,"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/channel_page?post=6028"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}